News
-
-
-
-
PRESS RELEASE
Cherry SE: Successful Analyst and Investor Day; preliminary figures for Q1 2024 above own forecast and market expectations; outlook for the current year confirmed
Cherry SE exceeds Q1 2024 preliminary figures in successful Analyst and Investor Day, confirming positive outlook for the year. Find out more at https://ir.cherry.de/home/publications/#presentations-webcasts -
-
PRESS RELEASE
Biotricity's Path Towards Breakeven Accelerated by Latest Diagnostic Product, Biotres Pro, Garnering Rapid Interest from Existing and New Customers
Biotricity Inc. experiences high demand for Biotres Pro - a revolutionary medical device expected to raise revenue by 10% in fiscal 2025. The device with premium features attracts existing and new customers -
-
-
-